65 related articles for article (PubMed ID: 27288791)
21. Corrigendum to "Clinical and genetic studies in patients with Lafora disease from Pakistan"[J. Neurol. Sci. 373 (2017) 263-267].
Ahmad A; Dad R; Ullah MI; Baig TA; Ahmad IN; Nasir A; Hübner CA; Hassan MJ
J Neurol Sci; 2017 Apr; 375():281. PubMed ID: 28320149
[No Abstract] [Full Text] [Related]
22. 5-Lipoxygenase (5-LOX) promoter polymorphism in patients with early-onset and late-onset Alzheimer's disease.
Qu T; Manev R; Manev H
J Neuropsychiatry Clin Neurosci; 2001; 13(2):304-5. PubMed ID: 11449041
[No Abstract] [Full Text] [Related]
23. Corrigendum to "Mortality of advanced Parkinson's disease patients treated with deep brain stimulation surgery" [J. Neurol. Sci. 369, 230-235].
Chung SJ
J Neurol Sci; 2016 Dec; 371():17. PubMed ID: 27871439
[No Abstract] [Full Text] [Related]
24. Corrigendum to "Sexual dysfunction in multiple sclerosis: A 6-year follow-up study" [J. Neurol. Sci. 358 (2015) 317-323].
Kisic-Tepavcevic D; Pekmezovic T; Trajkovic G; Stojsavljevic N; Dujmovic I; Mesaros S; Drulovic J
J Neurol Sci; 2017 Jan; 372():201. PubMed ID: 28017212
[No Abstract] [Full Text] [Related]
25. Conversion of pro-inflammatory murine Alox5 into an anti-inflammatory 15S-lipoxygenating enzyme by multiple mutations of sequence determinants.
Hofheinz K; Kakularam KR; Adel S; Anton M; Polymarasetty A; Reddanna P; Kuhn H; Horn T
Arch Biochem Biophys; 2013 Feb; 530(1):40-7. PubMed ID: 23246375
[TBL] [Abstract][Full Text] [Related]
26. Deletion of Alox5 gene decreases osteogenic differentiation but increases adipogenic differentiation of mouse induced pluripotent stem cells.
Wu Y; Sun H; Song F; Huang C; Wang J
Cell Tissue Res; 2014 Oct; 358(1):135-47. PubMed ID: 24906289
[TBL] [Abstract][Full Text] [Related]
27. Corrigendum to "Age-related changes of inactivating BK channels in rat dorsal root ganglion neurons" [J. Neurol. Sci 358 (1-2) (November 15 2015) 138-145].
Yu W; Lin X; Gao S; Li C
J Neurol Sci; 2016 May; 364():200-1. PubMed ID: 27084244
[No Abstract] [Full Text] [Related]
28. Corrigendum to "A new PLA2G6 mutation in a family with infantile neuroaxonal dystrophy" [J. Neurol. Sci. 381C (2017) 209-212].
Iannello G; Graziano C; Cenacchi G; Cordelli DM; Zuntini R; Papa V; Magistà AM; Gagliardi M; Procopio R; Quattrone A; Annesi G
J Neurol Sci; 2018 Feb; 385():238. PubMed ID: 29254810
[No Abstract] [Full Text] [Related]
29. Corrigendum to "Mortality and morbidity among hospitalized adult patients with neurological diseases in Cameroon" [J. Neurol. Sci. 381C (2017) 156-168].
Kompoliti K; Doumbe J; Mapoure YN; Nyinyikua T; Ouyang B; Shah H; Calvo S; Fernandez-Sierra A; Cubo E
J Neurol Sci; 2018 Feb; 385():237. PubMed ID: 29274952
[No Abstract] [Full Text] [Related]
30. Corrigendum to "The lipoxygenase pathway in zebrafish. Expression and characterization of zebrafish ALOX5 and comparison with its human ortholog" [Biochim. Biophys. Acta 1861/1, (2016) 1-11].
Adel S; Heydeck D; Kuhn H; Ufer C
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Feb; 1862(2):282. PubMed ID: 28341054
[No Abstract] [Full Text] [Related]
31. 5-Lipoxygenase pathway gene polymorphisms: lack of association with asthma in a Spanish population.
Torres-Galván SM; Cumplido JA; Buset N; Caballero-Hidalgo A; Blanco C; Hernández E; Carrillo T
J Investig Allergol Clin Immunol; 2009; 19(6):453-8. PubMed ID: 20128419
[TBL] [Abstract][Full Text] [Related]
32. SAR-studies of γ-secretase modulators with PPARγ-agonistic and 5-lipoxygenase-inhibitory activity for Alzheimer's disease.
Flesch D; Ness J; Lamers C; Dehm F; Popella S; Steri R; Ogorek I; Hieke M; Dannhardt G; Werz O; Weggen S; Schubert-Zsilavecz M
Bioorg Med Chem Lett; 2015 Feb; 25(4):841-6. PubMed ID: 25575659
[TBL] [Abstract][Full Text] [Related]
33. Copy number variation in ALOX5 and PTGER1 is associated with NSAIDs-induced urticaria and/or angioedema.
Plaza-Serón Mdel C; Ayuso P; Pérez-Sánchez N; Doña I; Blanca-Lopez N; Flores C; Galindo L; Molina A; Perkins JR; Cornejo-García JA; Agúndez JA; García-Martín E; Campo P; Canto G; Blanca M
Pharmacogenet Genomics; 2016 Jun; 26(6):280-7. PubMed ID: 26959713
[TBL] [Abstract][Full Text] [Related]
34. Amelioration of the Alzheimer's disease phenotype by absence of 12/15-lipoxygenase.
Yang H; Zhuo JM; Chu J; Chinnici C; Praticò D
Biol Psychiatry; 2010 Nov; 68(10):922-9. PubMed ID: 20570249
[TBL] [Abstract][Full Text] [Related]
35. In response to letter to Editor by Nosaka et al. on our paper: Elevated serum levels of neutrophil elastase in patients with influenza virus-associated encephalopathy. J Neurol Sci 2015;349:190-195.
Haginoya K; Sun G; Ota C; Kitaoka S; Takayanagi M; Kitamura T; Uematsu M; Hino-Fukuyo N; Munakata M; Kure S
J Neurol Sci; 2017 Jan; 372():50. PubMed ID: 28017246
[No Abstract] [Full Text] [Related]
36. 5-Lipoxygenase is a direct p53 target gene in humans.
Gilbert B; Ahmad K; Roos J; Lehmann C; Chiba T; Ulrich-Rückert S; Smeenk L; van Heeringen S; Maier TJ; Groner B; Steinhilber D
Biochim Biophys Acta; 2015 Aug; 1849(8):1003-16. PubMed ID: 26070487
[TBL] [Abstract][Full Text] [Related]
37. Re. "Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11 C-methionine in the determination of malignancy of gliomas" by Borbély et al. [J Neurol Sci 246 (2006) 85-94].
Trón L
J Neurol Sci; 2007 Dec; 263(1-2):232; author reply 232-3; discussion 233. PubMed ID: 17935735
[No Abstract] [Full Text] [Related]
38. Involvement of 5-lipoxygenase in Alzheimer's disease: a role for DNA methylation.
Di Francesco A; Arosio B; Gussago C; Dainese E; Mari D; D'Addario C; Maccarrone M
J Alzheimers Dis; 2013; 37(1):3-8. PubMed ID: 23727898
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
